A randomised controlled trial of cytological surveillance versus patient choice between surveillance and colposcopy in managing mildly abnormal cervical smears

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN14634238

Enrollment

476

Registered

2004-01-23

Start date

2002-01-01

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer (neoplasms): Cervix Cancer Malignant neoplasm of cervix uteri

Interventions

1. Normal procedure of repeat smear in 6 months. If normal, a further repeat smear at 12 months. If smear at 6 months was abnormal, colposcopy was undertaken. 2. Patient choice given between colposcop

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Women with mildly abnormal cervical smears

Exclusion criteria

Exclusion criteria: Pregnancy or abnormal vaginal bleeding.

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026